Delirium and Other Neuropsychiatric Manifestations of COVID-19 (With CE)

Delirium and Other Neuropsychiatric Manifestations of COVID-19 (With CE)

$40.00

Presenter:  Dr. Scott Beach

Dr. Scott R. Beach is the Program Director for the MGH/McLean Adult Psychiatry Residency, an attending psychiatrist on the MGH Psychiatry Consultation and Acute Psychiatric Services, and an Assistant Professor of Psychiatry at Harvard Medical School. He attended the University of Virginia School of Medicine and completed a residency in Adult Psychiatry at the University of Virginia. He finished a fellowship in Consultation-Liaison Psychiatry at the Massachusetts General Hospital in 2011 and was awarded Dupont-Warren and Livingston research fellowships through HMS. Dr. Beach has developed clinical and scholarly areas of expertise in QT prolongation and psychiatric medications, catatonia and related syndromes, and deception syndromes. He has authored over 50 peer-reviewed publications and more than 25 book chapters, and has edited two books. He has received multiple teaching awards including the MGH Department of Psychiatry’s Clinical Mentorship Award, is a fellow in the ACLP and APA, and was the inaugural recipient of the Early Achievement Award from the UVA Medical Alumni Foundation. 

Overview:         

This presentation is based on work conducted by our research group on the neuropsychiatric effects of COVID-19. It has been presented at several different venues, including Grand Rounds presentations at multiple academic medical centers. 

Learning Objectives:

  1. List the various ways in which COVID can present with neuropsychiatric symptoms
  2. Describe possible pathophysiological explanations for COVID’s effect on the CNS
  3. Describe an approach to managing delirium in COVID-19 patients
Categories: ,

Description

Presenter:  Dr. Scott Beach

 

Dr. Scott R. Beach is the Program Director for the MGH/McLean Adult Psychiatry Residency, an attending psychiatrist on the MGH Psychiatry Consultation and Acute Psychiatric Services, and an Assistant Professor of Psychiatry at Harvard Medical School. He attended the University of Virginia School of Medicine and completed a residency in Adult Psychiatry at the University of Virginia. He finished a fellowship in Consultation-Liaison Psychiatry at the Massachusetts General Hospital in 2011 and was awarded Dupont-Warren and Livingston research fellowships through HMS. Dr. Beach has developed clinical and scholarly areas of expertise in QT prolongation and psychiatric medications, catatonia and related syndromes, and deception syndromes. He has authored over 50 peer-reviewed publications and more than 25 book chapters, and has edited two books. He has received multiple teaching awards including the MGH Department of Psychiatry’s Clinical Mentorship Award, is a fellow in the ACLP and APA, and was the inaugural recipient of the Early Achievement Award from the UVA Medical Alumni Foundation. 

 

Overview:         

This presentation is based on work conducted by our research group on the neuropsychiatric effects of COVID-19. It has been presented at several different venues, including Grand Rounds presentations at multiple academic medical centers. 

 

Learning Objectives:

  1. List the various ways in which COVID can present with neuropsychiatric symptoms
  2. Describe possible pathophysiological explanations for COVID’s effect on the CNS
  3. Describe an approach to managing delirium in COVID-19 patients

Related products